AI Article Synopsis

  • Blue nevus-like lesions are noted for their blue color, located in the dermis, and show intense pigmentation; they are classified by the WHO into benign, intermediate malignant, and malignant categories.
  • Clinically, blue nevi are stable with distinct blue pigmentation, while new or rapidly growing lesions suggest a higher risk of malignancy, displaying additional irregular features.
  • Differentiating between lesions with intermediate malignant potential and melanoma is difficult, requiring thorough analysis of their histological characteristics.

Article Abstract

Blue nevus-like lesions constitute a category of melanocytic lesions that are clinically identified by their blue coloration. Histologically, they exhibit two primary features: a dermal location and intense pigmentation. The latest World Health Organization classification categorizes blue melanocytic lesions into benign entities (dermal melanocytoses, blue nevus, and deep penetrating nevus), melanocytic tumors with low-to-intermediate malignant potential (pigmented epithelioid melanocytoma), and malignant lesions (blue nevus-like melanoma and melanoma arising in blue nevi). Clinically, blue nevi are enduring and stable lesions, displaying a structureless blue pigmentation clinically and dermatoscopically, with a straightforward histologic diagnosis. On the contrary, lesions with recent onset and/or rapid growth are more commonly associated with diagnoses falling within the intermediate part of the spectrum or with melanoma. These lesions often present with a blue color along with additional features such as black blotches, irregular vessels, and irregular pigmented globules. They typically emerge de novo without recognizable precursors, and they pose significant challenges for patient management. Melanoma on a blue nevus is an exceedingly rare entity with only a few cases described to date. Histologically, differentiating between lesions with intermediate malignant potential and melanoma is always challenging, necessitating a comprehensive evaluation of all morphologic findings of the lesion.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clindermatol.2024.09.003DOI Listing

Publication Analysis

Top Keywords

blue nevus-like
12
blue nevus
12
blue
11
lesions
9
nevus-like lesions
8
pigmented epithelioid
8
epithelioid melanocytoma
8
melanoma blue
8
melanocytic lesions
8
malignant potential
8

Similar Publications

Article Synopsis
  • Blue nevus-like lesions are noted for their blue color, located in the dermis, and show intense pigmentation; they are classified by the WHO into benign, intermediate malignant, and malignant categories.
  • Clinically, blue nevi are stable with distinct blue pigmentation, while new or rapidly growing lesions suggest a higher risk of malignancy, displaying additional irregular features.
  • Differentiating between lesions with intermediate malignant potential and melanoma is difficult, requiring thorough analysis of their histological characteristics.
View Article and Find Full Text PDF
Article Synopsis
  • - NRAS Q61 mutations are common in melanocytic nevi and were found in a unique case of a 71-year-old Japanese man with a melanocytic tumor that had characteristics similar to a blue nevus.
  • - Histopathological analysis showed dense spindle-shaped melanocytes, with additional features like hyperpigmentation and mild nuclear atypia; targeted RNA sequencing confirmed two mutations (NRAS c.182A>G and FGFR2 c.-157A>G) without other significant alterations.
  • - Despite presenting similar morphology to a compound-type blue nevus ("Kamino nevus"), the tumor genetically aligns more closely with conventional melanocytic nevi driven by NRAS mutations, lacking the coexistence of ID
View Article and Find Full Text PDF

Dermoscopic features of nevoid melanoma: a retrospective study.

Ital J Dermatol Venerol

October 2022

Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy.

Background: Nevoid melanoma (NeM) is a rare variant of melanoma resembling melanocytic nevus. The aim of the study was to systematically review the dermoscopic features of NeM.

Methods: A hospital-based retrospective study was conducted.

View Article and Find Full Text PDF

Preferentially expressed antigen in melanoma (PRAME) is an immunohistochemical biomarker that is diffusely expressed in most cutaneous melanomas and is negative in most benign nevi. Histologically challenging dermal melanocytic neoplasms, such as cellular blue nevi (CBN) and deep penetrating nevi (DPN), and soft tissue tumors with melanocytic differentiation, such as clear cell sarcoma and perivascular epithelioid cell tumor, may resemble primary or metastatic melanoma. PRAME immunohistochemistry (IHC) was applied to archived formalin-fixed, paraffin-embedded specimens of various dermal melanocytic neoplasms and soft tissue neoplasms with melanocytic differentiation.

View Article and Find Full Text PDF

Distinguishing cellular blue nevi (CBNs) and atypical CBNs from blue nevus-like melanoma (BNLM) can be diagnostically challenging. Immunohistochemistry may inform the diagnosis in a subset of cases but is not always diagnostic. Further, ancillary molecular testing is expensive and often requires significant tissue to complete.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!